Kalela A - Search Results

1

Hematocrit and the risk of coronary heart disease mortality in the TAMRISK study, a 28-year follow-up.

Kunnas T, Solakivi T, Huuskonen K, Kalela A, Renko J, Nikkari ST. Kunnas T, et al. Among authors: kalela a. Prev Med. 2009 Aug;49(1):45-7. doi: 10.1016/j.ypmed.2009.04.015. Epub 2009 May 3. Prev Med. 2009. PMID: 19409924

2

Late-life coronary heart disease mortality of Finnish war veterans in the TAMRISK study, a 28-year follow-up.

Kunnas T, Solakivi T, Renko J, Kalela A, Nikkari ST. Kunnas T, et al. Among authors: kalela a. BMC Public Health. 2011 Feb 1;11(1):71. doi: 10.1186/1471-2458-11-71. BMC Public Health. 2011. PMID: 21284848 Free PMC article.

3

Gln27Glu variant of Beta2-adrenoceptor gene affects male type fat accumulation in women.

Kunnas T, Lahtio R, Kortelainen ML, Kalela A, Nikkari ST. Kunnas T, et al. Among authors: kalela a. Lipids Health Dis. 2009 Oct 15;8:43. doi: 10.1186/1476-511X-8-43. Lipids Health Dis. 2009. PMID: 19832974 Free PMC article.

4

Serum homocysteine does not associate with uncomplicated coronary heart disease.

Nikkari ST, Kalela A, Koivu TA, Koivula T, Alho H, Jokela H, Sillanaukee P. Nikkari ST, et al. Among authors: kalela a. Eur J Clin Invest. 2001 Jul;31(7):581-5. doi: 10.1046/j.1365-2362.2001.00853.x. Eur J Clin Invest. 2001. PMID: 11454012

5

Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease.

Kalela A, Koivu TA, Sisto T, Kanervisto J, Höyhtyä M, Sillanaukee P, Lehtimäki T, Nikkari ST. Kalela A, et al. Scand J Clin Lab Invest. 2002;62(5):337-42. doi: 10.1080/00365510260296483. Scand J Clin Lab Invest. 2002. PMID: 12387578

6

Serum matrix metalloproteinase-9 is elevated in men with a history of myocardial infarction.

Renko J, Kalela A, Jaakkola O, Laine S, Höyhtyä M, Alho H, Nikkari ST. Renko J, et al. Among authors: kalela a. Scand J Clin Lab Invest. 2004;64(3):255-61. doi: 10.1080/00365510410006054. Scand J Clin Lab Invest. 2004. PMID: 15222636

7

Association of serum sialic acid and MMP-9 with lipids and inflammatory markers.

Kalela A, Pönniö M, Koivu TA, Höyhtyä M, Huhtala H, Sillanaukee P, Nikkari ST. Kalela A, et al. Eur J Clin Invest. 2000 Feb;30(2):99-104. doi: 10.1046/j.1365-2362.2000.00607.x. Eur J Clin Invest. 2000. PMID: 10651833

8

Association of serum MMP-9 with autoantibodies against oxidized LDL.

Kalela A, Koivu TA, Höyhtyä M, Jaakkola O, Lehtimäki T, Sillanaukee P, Nikkari ST. Kalela A, et al. Atherosclerosis. 2002 Jan;160(1):161-5. doi: 10.1016/s0021-9150(01)00553-6. Atherosclerosis. 2002. PMID: 11755934

9

Association of carbohydrate-deficient transferrin (CDT) and gamma-glutamyl-transferase (GGT) with serum lipid profile in the Finnish population.

Nikkari ST, Koivu TA, Kalela A, Strid N, Sundvall J, Poikolainen K, Jousilahti P, Alho H, Sillanaukee P. Nikkari ST, et al. Among authors: kalela a. Atherosclerosis. 2001 Feb 1;154(2):485-92. doi: 10.1016/s0021-9150(00)00502-5. Atherosclerosis. 2001. PMID: 11166783

10

Lipoprotein docosapentaenoic acid is associated with serum matrix metalloproteinase-9 concentration.

Solakivi T, Jaakkola O, Kalela A, Pispa M, Salomäki A, Lehtimäki T, Höyhtyä M, Jokela H, Nikkari ST. Solakivi T, et al. Among authors: kalela a. Lipids Health Dis. 2005 Apr 13;4:8. doi: 10.1186/1476-511X-4-8. Lipids Health Dis. 2005. PMID: 15826319 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters